ANXA5 also known as Annexin A5 is a Protein Coding gene. Some of the diseases associated with ANXA5 are pregnancy loss, recurrent pregnancy loss, and antiphospholipid syndrome. It is related to pathways such as Apoptosis-related network caused by altered Notch3 in ovarian cancer and Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway. This gene is annotated as calcium ion binding and calcium-dependent phospholipid binding in Gene Ontology (GO). The paralog of this gene is ANXA4. It belongs to the annexin family of proteins. As a flow cytometer, annexin V can be used to detect apoptotic cells due to its affinity for phosphatidylserine, which is a marker of apoptosis when it is found in the plasma membrane. There is no known function of annexin A5, but it has been proposed that it inhibits blood coagulation by competing for phosphatidylserine binding sites with prothrombin and inhibiting the activity of phospholipase A1.
FutureWise Market Research has instantiated a report that provides an intricate analysis of ANXA5 Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the ANXA5 Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.